Sexual Health

Men’s sexual health is one of those topics where the medicine is mostly straightforward and the conversation is mostly impossible. The biology is well-mapped, the drugs work, the referral pathways are clear. What gets in the way is the fifteen years a guy waits before bringing it up, and then the ninety seconds his primary care doctor spends on it before refilling his lisinopril and moving on. The field’s bottleneck on this isn’t pharmacology, it’s that nobody asks the question out loud and nobody volunteers it.

The version that walks in goes like this. A man comes in for “low mood” or “stress” or because his wife told him to, and somewhere in the third visit, when he trusts the room enough, the actual problem arrives. He hasn’t been getting hard reliably for two years. Or his libido fell off a cliff at 47 and he’s been quietly assuming this is just what aging is. Or he’s been on Zoloft for eight years and nobody told him the reason he can’t finish anymore is the medication, so he’s been thinking it was him.

None of this is exotic, most of it is fixable or at least negotiable. The piece that takes work is getting the information out of him in the first place.

The patient who has been quietly miserable about this for two years and finally brings it up usually has it fixed inside a month.

The first split: vascular versus head versus medication

The first useful split in ED (erectile dysfunction, the umbrella term for not getting hard, not staying hard, or not getting hard enough) is whether the plumbing works or the wiring is the problem. The test for that is embarrassingly simple. The two diagnostic questions are whether you’re getting hard in the morning and whether you’re getting hard when you’re alone with no audience and no pressure. If yes to either, the plumbing is fine, the problem is in the head, not the parts… anxiety, the marriage, performance pressure, depression, a head full of work. If the morning erections have quietly disappeared over the last year or two and you can’t get one going on your own either, that’s a vascular or hormonal problem and we actually need to work it up. Different problem, different fix.

This matters because the workup splits hard at that fork. The head version is psychiatry’s lane, and the real fix is treating whatever’s upstream: anxiety, depression, the performance-anxiety feedback loop where you started worrying about it and now the worry is the thing keeping it from working, sometimes a marriage that hasn’t had sex in two years and the avoidance has hardened into a habit. The plumbing version is a cardiovascular signal, and new-onset ED in a guy under 50 is genuinely a finding that should trigger a lipid panel and a frank conversation with his PCP, not just a Viagra script. The arteries running into your groin (the cavernous arteries, the ones that fill the penis with blood) are smaller than the ones running into your heart, so they clog first. If your stuff still works in the morning, it’s not the plumbing, it’s the head.

For the PDE5 inhibitor specifics, the daily-versus-PRN tadalafil question, the premature ejaculation pharmacology, see the deep dive on sexual performance. This post is about figuring out what’s actually wrong before reaching for a pill.

Then there’s the medication-induced version, which is its own category and gets missed by the field constantly. We’ll get to that.

ED and BPH: same biology, very different insurance treatment

This is a thing almost nobody puts in print, which is half the reason I’m putting it here. ED and BPH (benign prostatic hyperplasia, the “having to pee three times a night and dribbling at the end” thing where your prostate has gotten bigger and is squeezing the urethra) show up in the same guy constantly, share a lot of the same underlying biology, and respond to many of the same treatments. But insurance covers the two of them like they were completely separate problems on separate planets.

The biology overlap is real. The penis, the bladder neck, and the prostate are all running on overlapping neurovascular wiring. When that wiring takes hits from age, hypertension, diabetes, metabolic syndrome, the ED and the urinary symptoms (the field calls them LUTS, lower urinary tract symptoms, basically getting up to pee at night plus weak stream plus frequency) show up together. The MSAM-7 multinational survey of nearly 13,000 men in their 50s to 80s found that the urinary symptoms are an independent risk factor for sexual dysfunction even after adjusting for age, diabetes, heart disease, and the rest.

Now the practical part. Tadalafil 5 mg daily is FDA-approved for both ED and BPH (the BPH indication came through in 2011). Same pill, same dose, addresses both problems. But when the diagnosis on the prescription is just ED, most commercial plans either won’t cover it or cap you at four or six pills a month. When the diagnosis is BPH, the same medication usually gets covered as a standard urology drug. Medicare Part D is the cleanest version of this, it explicitly won’t cover Cialis for ED but will cover it for BPH.

What this means in practice: if you have any urinary symptoms (frequency, urgency, weak stream, getting up at night, hesitancy starting), tell your prescriber about them honestly. If you genuinely have BPH symptoms, you have a clinically valid reason to be on daily tadalafil under the BPH indication, and that gets you the medication you needed anyway at a price you can actually afford. The two diagnoses are real, the treatment is appropriate for both, the system just decided to price one of them out of your insurance. Wait, can I say that? I just did. That’s how the system actually works.

Low libido is usually not what you think

Guys walk in convinced their testosterone is the issue. Sometimes it is. More often it isn’t. The bigger drivers of low libido in middle-aged men, in rough order of how often they turn out to be the real story, are depression, the marriage having quietly gone sexless over the last few years, sleep apnea, alcohol use, chronic work stress, and antidepressants. Testosterone is usually a symptom of most of those, not the cause. You can hand a guy a tube of testosterone gel and his number will go up, and if the underlying issue was that he hates his job and sleeps five hours a night and his wife has been on the other end of the bed for two years, his libido isn’t coming back from a hormone.

Half of “low libido in middle age” is a life problem wearing a hormone costume. The shot rearranges the symptoms without touching the actual thing.

For the full picture on testosterone (the workup, who actually has hypogonadism, why the standard 300 ng/dL floor is way too low for younger men), see the dedicated testosterone piece. The short version: if your number is in the gray zone, work up the life factors first, because most of the time those are what’s actually driving the libido drop, and the testosterone often comes back up on its own when they get addressed.

Medication-induced sexual dysfunction, the one that bothers me most

This is the one that bothers me most, because it’s common, well-documented, and routinely just… not discussed. SSRIs and SNRIs are the worst offenders but they’re not the only ones. The medications that quietly tank sexual function, in rough order of how often it comes up:

SSRIs and SNRIs. Somewhere between half and three-quarters of patients on them describe some sexual side effect depending on which drug and how the question is asked (Montejo’s 2001 study found 58 to 73 percent across SSRIs and venlafaxine). Paroxetine and sertraline are usually the worst offenders. Escitalopram and citalopram are roughly in the middle. Bupropion and mirtazapine are the cleanest, which is why they end up being the workaround for a lot of patients.

Beta blockers. The older ones (propranolol, metoprolol) flatten libido and impair getting hard at clinically meaningful rates. Carvedilol and nebivolol are cleaner. If a guy is on metoprolol for blood pressure and his sex life cratered in the year after starting, that’s a conversation with the prescriber, not a Viagra prescription on top of the metoprolol.

Thiazide diuretics. Hydrochlorothiazide in particular. Mechanism isn’t totally pinned down, the effect is real, switching to a different blood-pressure drug class usually fixes it.

Finasteride. Sexual side effects in the low single digits during use, mostly reversible, with a small persistent-symptom group that’s its own conversation (see hair loss for the full PFS piece).

Spironolactone. Anti-androgen by its mechanism, used for blood pressure or heart failure or hormonal acne, the libido cost is direct.

Antipsychotics. Risperidone is the worst offender via prolactin elevation (a pituitary hormone that suppresses sex drive when it gets cranked up). Tanks desire across the board. Aripiprazole is the cleanest of the newer antipsychotics on this metric.

Two things keep all of this buried. Clinicians don’t ask, because the visit is fifteen minutes and the original problem is the headline. Patients don’t volunteer, because they’re embarrassed, or they assume it’s the underlying condition itself, or they don’t want their psychiatrist to take them off the medication that’s finally keeping them functional. So both sides agree to not bring it up, and the patient quietly stops taking the medication six months later and ends up back in a crisis nobody saw coming. That’s how the system fails the guy who didn’t even know there was something to ask about.

The honest conversation, when it actually happens, sounds something like this: yes, this medication might flatten your libido or make it hard to climax or both. Here are the options. We can switch to bupropion, we can add bupropion on top, we can lower the dose, we can try a weekend drug holiday on some SSRIs (won’t work on paroxetine because the half-life is too short and you’ll get withdrawal), we can switch to a different SSRI, we can accept the trade-off for a year while the depression heals and revisit it later. The point is that the trade-off is yours to make, you’re a grown man, my job is to lay out the options, your job is to pick. I’m a provider, not a parent.

There’s also a small group of patients who develop sexual problems that don’t go away after they stop the medication, called PSSD, post-SSRI sexual dysfunction. It’s a real entity that the field spent too long pretending wasn’t real. The mechanism isn’t well-understood. The reports describe symptoms hanging around for years after stopping the drug. If you suspect you have it, document the timeline, talk to a psychiatrist who’s willing to take it seriously, and stay clear of anybody who tells you it’s all psychological. It might be, in some cases, and it also might not be, and the honest answer is we don’t know yet.

What’s nice to hear about the SSRI piece

Lead with the warnings because that’s the default and then reverse it now. The workaround actually works for a lot of guys. Adding bupropion 150 to 300 mg on top of an SSRI is one of the more reliable moves in psychiatry, reverses the sexual side effects for a real chunk of patients, and often helps the depression on top. Switching to bupropion alone, when the patient’s depression is the kind that responds to it, gives back the libido and the orgasm without losing the antidepressant effect. The PDE5 inhibitors (sildenafil, tadalafil) work fine alongside SSRIs and don’t conflict. The patient who has been quietly miserable about this for two years and finally brings it up usually has it fixed inside a month, and the relief is bigger than the original problem was, because he’s also relieved he’s no longer carrying it alone. That’s the part nobody puts in the package insert.

Premature ejaculation and Peyronie’s, brief because they’re not the focus here

Premature ejaculation is usually treatable, almost never discussed, and outside this post’s scope. Off-label SSRIs at lower doses than depression dosing, topical lidocaine sprays, behavioral techniques. The data is reasonable. See sexual performance for the PE deep dive.

Peyronie’s disease (a condition where scar tissue in the penis causes painful or curved erections) is a urology problem, not a psychiatry problem. If a guy describes new curvature, palpable plaque, painful erections, or a noticeable change in shape, he needs a urologist. Same for any blood in the urine, scrotal masses, or testicular pain. I’ll sometimes co-manage the psychological piece, because Peyronie’s wrecks men psychologically more than the size of the actual problem suggests it should, but I’m not the one driving the treatment plan there.

Where I land, and where you land is yours

Patient autonomy stuff applies here too. If you want the PDE5 prescription, you get it. If you want to switch your SSRI to bupropion to get the orgasm back, you get the switch. If you want to ride out the side effects for a year while the depression heals and revisit later, that’s also a real choice. My job is the honest take, your job is what you do with it. I’m a provider, not a parent, and the appointment isn’t mine.

The clinical stuff above is the easy part. The harder part is that a lot of guys will read this, recognize themselves, and still not bring it up at their next appointment. They’ll mention their knee, their reflux, their blood pressure. Not this. The cost of that silence is years of quietly diminished life, and depressions that get worse because the medication that was helping is also gutting something they care about and nobody asked.

If you’re sitting on something in this category, write it down before the appointment so you actually say it. A doctor who’s any good won’t be surprised and will have heard a version of it earlier the same week. The thing you’re hesitant to say is one of the more common reasons men over 40 are in any psychiatrist’s chair in the first place.

Sources

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. PMID 8254833.
2. Rosen R, Altwein J, Boyle P, et al. Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7). Eur Urol. 2003;44(6):637-649. PMID 14644114.
3. Dong JY, Zhang YH, Qin LQ. Erectile Dysfunction and Risk of Cardiovascular Disease: Meta-Analysis of Prospective Cohort Studies. J Am Coll Cardiol. 2011;58(13):1378-1385. PMID 21920268.
4. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry. 2001;62 Suppl 3:10-21. PMID 11229449.
5. Porst H, Kim ED, Casabé AR, et al. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Eur Urol. 2011;60(5):1105-1113. PMID 21871706.
6. Bala A, Nguyen HMT, Hellstrom WJG. Post-SSRI Sexual Dysfunction: A Literature Review. Sex Med Rev. 2018;6(1):29-34. PMID 28778697.
7. Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev, 2013, (5):CD003382. PMID 23728643.